Novo Nordisk A/S (NVO) News Today $54.28 0.00 (0.00%) Closing price 03:59 PM EasternExtended Trading$54.16 -0.12 (-0.22%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Novo Nordisk A/S Up Today?Toggle Visibility of Why Is Novo Nordisk A/S Up Today?Novo Nordisk A/S (NYSE: NVO) shares are trading around $54.28 amid a mix of analyst actions, legal developments and competitive dynamics. Below is a summary of key headlines for investors: Positive Sentiment: Sanford C. Bernstein upgraded Novo Nordisk from “market perform” to “outperform,” reflecting increased confidence in the company’s growth trajectory. The Fly Positive Sentiment: Seeking Alpha praises Novo Nordisk as a pharma leader with strong fundamentals and defensive appeal, driven by its leading GLP-1 drugs and significant global expansion opportunities. Seeking Alpha Positive Sentiment: Novonesis and Novo Nordisk entered a research collaboration to explore new metabolic-health solutions, enhancing the company’s R&D pipeline. GlobeNewswire Neutral Sentiment: Zacks.com flags Novo Nordisk as a trending stock, advising investors to familiarize themselves with key facts and upcoming catalysts before placing bets on NVO. Zacks Negative Sentiment: Multiple law firms—Pomerantz, Levi & Korsinsky, Bronstein Gewirtz & Grossman, Bernstein Liebhard and The Gross Law Firm—issued class-action and securities-fraud alerts, notifying investors of deadlines to lead or join lawsuits against Novo Nordisk, underscoring elevated legal risk. PR Newswire Negative Sentiment: The Motley Fool warns that Eli Lilly’s obesity drug Zepbound is gaining share at the expense of Novo Nordisk’s Wegovy, highlighting intensifying competition in the weight-loss market. The Motley Fool Posted 1h agoAI Generated. May Contain Errors. NVO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitSeptember 9 at 12:00 PM | prnewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 30, 2025 in Novo Nordisk A/S Lawsuit - NVOSeptember 9 at 9:00 AM | prnewswire.com1 Reason Every Investor Should Know About Novo Nordisk (NVO)September 8 at 9:00 PM | fool.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 30, 2025 in Novo Lawsuit – NVOSeptember 8 at 4:17 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVOSeptember 8 at 2:01 PM | prnewswire.comNVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitSeptember 8 at 12:00 PM | globenewswire.comNOVO NORDISK A/S (NYSE: NVO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Novo Nordisk A/S Investors of Upcoming DeadlineSeptember 8 at 10:28 AM | globenewswire.comNovo Nordisk: A Pharma Leader With Growth Potential And Portfolio-Defensive AppealSeptember 8 at 10:15 AM | seekingalpha.comNovo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NVOSeptember 8 at 8:45 AM | prnewswire.comSepio Capital LP Purchases 7,455 Shares of Novo Nordisk A/S $NVOSeptember 8 at 5:41 AM | marketbeat.comNovonesis and Novo Nordisk will explore new solutions to improve metabolic healthSeptember 8 at 2:43 AM | globenewswire.comPosse of U.S. Law Firms Saddles Up for Court Showdown with Novo Nordisk (NVO)September 7 at 12:55 AM | msn.comFaruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVOSeptember 7 at 12:46 PM | globenewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVOSeptember 7 at 11:11 AM | markets.businessinsider.comNovo Nordisk (NYSE:NVO): Assessing Valuation After Recent Share Price SwingsSeptember 7 at 10:59 AM | finance.yahoo.comParkwood LLC Buys 200,976 Shares of Novo Nordisk A/S $NVOSeptember 7 at 7:44 AM | marketbeat.comNFJ Investment Group LLC Has $6.53 Million Stake in Novo Nordisk A/S $NVOSeptember 7 at 6:43 AM | marketbeat.comNewEdge Advisors LLC Increases Stake in Novo Nordisk A/S $NVOSeptember 7 at 6:36 AM | marketbeat.comLevi & Korsinsky Notifies Shareholders of Novo Nordisk A/S (NVO) of a Class Action Lawsuit and an Upcoming DeadlineSeptember 7 at 5:58 AM | theglobeandmail.comNovo Nordisk A/S (NYSE:NVO) Trading Down 1.7% - Here's What HappenedSeptember 6 at 5:12 PM | marketbeat.comROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVOSeptember 6 at 10:12 AM | globenewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo NordiskSeptember 6 at 10:09 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVOSeptember 6 at 10:00 AM | globenewswire.comNVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud LawsuitSeptember 6 at 7:41 AM | prnewswire.comNovo Nordisk A/S $NVO Shares Bought by Curi RMB Capital LLCSeptember 6 at 5:56 AM | marketbeat.comFocus Partners Advisor Solutions LLC Buys New Position in Novo Nordisk A/S $NVOSeptember 6 at 4:48 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Trading Down 1.3% - Here's WhySeptember 5, 2025 | marketbeat.comNovo Nordisk: Keep It Low So I Can Keep Accumulating (Rating Upgrade)September 5, 2025 | seekingalpha.comSeptember 30, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NVOSeptember 5, 2025 | globenewswire.comNovo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitSeptember 5, 2025 | prnewswire.comNovo Nordisk Vs. Eli Lilly: Novo A Clear WinnerSeptember 5, 2025 | seekingalpha.comNovo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights - NVOSeptember 5, 2025 | prnewswire.comNovo Nordisk A/S $NVO Holdings Raised by AmundiSeptember 5, 2025 | marketbeat.comFederation des caisses Desjardins du Quebec Raises Holdings in Novo Nordisk A/S $NVOSeptember 5, 2025 | marketbeat.comNovo Nordisk A/S $NVO Holdings Decreased by EP Wealth Advisors LLCSeptember 5, 2025 | marketbeat.comNovo Nordisk Woes and Trump’s Tariffs Dent Danish Growth OutlookSeptember 5, 2025 | bloomberg.comNovo Nordisk A/S Class Action: Levi & Korsinsky Reminds Novo Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 30, 2025 - NVOSeptember 5, 2025 | theglobeandmail.comNovo Nordisk to present new semaglutide data on ‘food noise', body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congressSeptember 5, 2025 | globenewswire.comNovo Nordisk A/S Class Action: The Gross Law Firm Reminds Novo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 – NVOSeptember 4, 2025 | globenewswire.comNovo Nordisk A/S (NYSE:NVO) Trading 1.3% Higher - What's Next?September 4, 2025 | marketbeat.comDEADLINE ALERT for SOC, LMT, NVO, and LINE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersSeptember 4, 2025 | globenewswire.comNYSE: NVO DEADLINE REMINDER: Berger Montague Reminds Nordisk A/S (NYSE: NVO) Investors of Important Class Action Lawsuit DeadlineSeptember 4, 2025 | prnewswire.comClass Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join - Contact The Gross Law FirmSeptember 4, 2025 | prnewswire.com121,600 Shares in Novo Nordisk A/S $NVO Bought by Bridger Management LLCSeptember 4, 2025 | marketbeat.com16,300 Shares in Novo Nordisk A/S $NVO Purchased by Graham Capital Management L.P.September 4, 2025 | marketbeat.comROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVOSeptember 3, 2025 | globenewswire.comGlobal drugmakers rush to boost US presence as tariff threat loomsSeptember 3, 2025 | reuters.comHealthy Returns: Novo Nordisk's head of research and development previews the first-ever obesity pillSeptember 3, 2025 | cnbc.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo NordiskSeptember 3, 2025 | globenewswire.comDeadline Alert: Novo Nordisk A/S (NVO) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitSeptember 3, 2025 | globenewswire.com Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.560.70▲Average Medical News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼5691▲NVO Articles Average Week Get the Latest News and Ratings for NVO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Novartis News Today AstraZeneca News Today Sanofi News Today GSK News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today Insmed News Today BioNTech News Today Teva Pharmaceutical Industries News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
